 |
Milestone Builds on Hong Kong’s Healthcare Professionals Choice Probiotic Award and Full US HSA/FSA Payment Eligibility
SINGAPORE, Sept. 21, 2026 /PRNewswire/ — Bened Life, the leader in psychobiotics, has completed voluntary notification for its flagship product, Neuralli™ MP, with Singapore’s Health Sciences Authority (HSA) under the Health Supplements framework (Notification No.: VNS-2026-08-00377) — reflecting the product’s continued alignment with local regulatory standards. The milestone marks the latest step in Bened Life’s expanding presence across the APAC region.
Under this framework, Neuralli™ MP has been notified for the general healthy population in accordance with the following health claims from HSA’s List of Health Claims for Health Supplements:
– Mental Performance: Contributes to normal mental performance (S/N 527)
– Emotional Wellbeing: Helps maintain / support emotional wellbeing (S/N 544)
– Sleep Support: Helps decrease/reduce/relieve disturbed/restless sleep (S/N 532)
– Stress Management: Supports healthy body stress recovery (S/N 568)
These notified claims are backed by PS128™ strain (Lactiplantibacillus plantarum PS128™), a probiotic strain extensively studied for its role in the gut-brain connection. PS128™ is a novel psychobiotic that appears to balance the “happy hormones” serotonin and dopamine, the “stress hormone” cortisol, and other molecules that affect neurological health, mood, stress response, and focus. Backed by more than 18 clinical studies, PS128™ continues to be studied for how it may support this connection between gut health and overall wellbeing.
The Singapore milestone builds on recent momentum in Hong Kong, where Neuralli™ MP won two major industry honors in as many years: the Healthcare Professional Choice Probiotic Award in 2026, voted on directly by the medical community, and the Best Psychobiotic Brand of the Year award in 2025. A survey by the Health Research Centre among Hong Kong healthcare professionals found that after one month of using Neuralli™ MP:
- Over 90% of surveyed HK HCPs recommend[1]
- 94.3% of surveyed HK HCPs reported improved focus[2]
- 93.1% of surveyed HK HCPs reported reduced work stress[3]
In the United States, Neuralli™ MP is now fully eligible for purchase through Health Savings Account (HSA) and Flexible Spending Account (FSA) funds, allowing US consumers to use pre-tax health benefit dollars to cover up to 100% of the cost.
“These results didn’t happen by chance,” said Frankie Cheng, CEO of Bened Life. “In just a few months, we’ve cleared regulatory bars in the region with Singapore’s HSA, won the trust of healthcare professionals in Hong Kong, and made Neuralli™ MP available to millions of Americans through HSA and FSA plans. Together, these achievements reflect a commitment that consumers around the world can now see, and benefit from. We will continue to build on this momentum as we expand across APAC and beyond.”
Looking ahead, Bened Life will continue to deepen its localized presence and scientific outreach across APAC, delivering science-backed, high-quality psychobiotic solutions to consumers worldwide and leading the next wave of innovation in gut-brain health.
About Bened Life
Bened Life is the leader in psychobiotics, dedicated to advancing gut-brain axis science through rigorous clinical research and uncompromising quality standards. The company’s flagship product, Neuralli™ MP, is built on the clinically studied PS128™ strain, backed by more than 18 clinical studies, and is trusted by consumers in more than 60 countries and regions. Guided by its mission to make science-backed mental wellness accessible to all, Bened Life continues to expand its footprint across the United States and Asia-Pacific while championing neurodiversity advocacy and research partnerships worldwide. Neuralli™ MP is available via the Bened Life official website.
|
[1] Out of 45 surveyed HCPs, 41 (91.1%) recommended this product. |
